EDGE Experience Diligence Guidance Execution


BIO Real Estate

Combining Life Science And Real Estate Expertise

The BIO Real Estate team offers its clients an unprecedented combination of executive-level real estate and life science experience to deliver real estate solutions tailored to the unique, mission-critical facility needs of the life science industry.

Using Our Experience For Your Success

Our life science executives have more than 60 years experience managing some of the area’s largest life science companies and guiding them through the design, approval, financing and development of their corporate headquarters. These individuals understand how real estate needs – and financing alternatives – can vary significantly for different types of companies within the life science industry (e.g. therapeutic, diagnostic, contract research, etc.) and/or their stage of development (e.g., pre-clinical, clinical, commercial). This first-hand knowledge gives us the unique ability to more effectively understand and evaluate our client’s real estate needs – not just from an operational standpoint, but from a strategic and financial perspective as well.

Our team of proven real estate professionals, in combination with our life science specialists, provides our clients with more than 150 years of collective experience in successfully delivering mission-critical real estate solutions. Our real estate principals have completed some of the largest life science real estate transactions in the mid-Atlantic region and, overall, have successfully concluded more than $6 billion in diverse commercial and life science real estate transactions. Representative transactions conducted by our life science and real estate professionals include:

  • $1.385 billion real estate monetization for Human Genome Sciences, Inc. – GWCAR’s “Sales & Finance Transaction of the Year – MD”
  • National site selection/incentive negotiation for MedImmune, Inc.’s world headquarters – Washington Business Journal’s “Best Office Lease – Suburban”
  • National site selection/incentive negotiation for the American Type Culture Collection’s 106,000-square-foot corporate headquarters and research facility
  • $92.5 million real estate disposition for Human Genome Sciences, Inc. – Washington Business Journal’s “Sale Transaction of the Year”
  • 53,000-square-foot financing/lease/build out of Large Scale Biology Corporation’s corporate research facility
  • Site selection/incentive negotiation for Human Genome Sciences, Inc.’s 127,000-square-foot pilot plant – Washington Business Journal’s “Best Industrial Transaction of the Year”
  • 30,000-square-foot financing/build-out and relocation of Osiris Therapeutic, Inc.’s corporate research facility
  • $8.5M disposition of a 58,000-square-foot biopharmaceutical manufacturing facility

Together, our extensive life science expertise and proven commercial real estate capabilities will provide our clients with a knowledgeable assessment of their needs and the successful execution of an effective solution.